S&P 500

5.469,30

0,39%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Tanox (MM) (TNOX)
Tanox (MM) (TNOX) Notícias

TNOX

Tanox (TNOX)

Tanox (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:TNOX

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
02/08/2007	18:30	PR Newswire (US)	HealthShares(TM) Announces Change to the HealthShares(TM) Respiratory/Pulmonary Index	NASDAQ:TNOX	Tanox (MM)
09/05/2007	18:02	PR Newswire (US)	Tanox Reports 2007 First Quarter Results	NASDAQ:TNOX	Tanox (MM)
15/03/2007	18:53	PR Newswire (US)	Tanox Reports Fourth Quarter and Full Year 2006 Results	NASDAQ:TNOX	Tanox (MM)
29/01/2007	11:36	PR Newswire (US)	Genentech and Tanox Receive 'Second Request' from the Federal Trade Commission	NASDAQ:TNOX	Tanox (MM)
15/01/2007	17:43	PR Newswire (US)	Tanox, Inc. Stockholders Approve Merger With Genentech, Inc.	NASDAQ:TNOX	Tanox (MM)
09/11/2006	20:50	PR Newswire (US)	Genentech Announces Agreement to Acquire Tanox for $20 Per Share	NASDAQ:TNOX	Tanox (MM)
02/11/2006	08:30	PR Newswire (US)	Tanox Reports 2006 Third Quarter Results	NASDAQ:TNOX	Tanox (MM)
25/10/2006	08:00	PR Newswire (US)	Tanox Initiates Phase 1 Clinical Trial Evaluating TNX-650 for Treatment of Asthma	NASDAQ:TNOX	Tanox (MM)
24/10/2006	19:10	PR Newswire (US)	Tanox to Report Third Quarter 2006 Financial Results, Host Conference Call for Investors Nov. 2	NASDAQ:TNOX	Tanox (MM)
14/09/2006	16:03	PR Newswire (US)	Tanox to Present at UBS Global Life Sciences Conference	NASDAQ:TNOX	Tanox (MM)
31/08/2006	09:00	PR Newswire (US)	Tanox to Present at the Bear Stearns Healthcare Conference	NASDAQ:TNOX	Tanox (MM)
17/08/2006	15:00	PR Newswire (US)	New Data Confirm Durable Response of TNX-355 Regimens Through 48 Weeks in Treatment-Experienced HIV Patients	NASDAQ:TNOX	Tanox (MM)
08/08/2006	07:30	PR Newswire (US)	Tanox Reports 2006 Second Quarter Results	NASDAQ:TNOX	Tanox (MM)
03/08/2006	19:45	PR Newswire (US)	Tanox Conducts Meeting With Food and Drug Administration Regarding Its HIV/AIDS Antibody, TNX-355	NASDAQ:TNOX	Tanox (MM)
18/07/2006	10:00	PR Newswire (US)	Tanox to Report Second Quarter 2006 Financial Results, Host Conference Call for Investors Aug. 8	NASDAQ:TNOX	Tanox (MM)
31/05/2006	20:21	PR Newswire (US)	Results of TNX-355 Combination Study Published in Antimicrobial Agents and Chemotherapy	NASDAQ:TNOX	Tanox (MM)
23/05/2006	07:00	PR Newswire (US)	First Patient Dosed in Phase 1 Trial of Tanox's TNX-650	NASDAQ:TNOX	Tanox (MM)
02/05/2006	07:00	PR Newswire (US)	Tanox Reports 2006 First Quarter Results	NASDAQ:TNOX	Tanox (MM)
02/05/2006	06:00	PR Newswire (US)	Tanox Reports 48-Week Results From TNX-355 Phase 2 Clinical Trial	NASDAQ:TNOX	Tanox (MM)
17/04/2006	17:30	PR Newswire (US)	Tanox to Present at Two Investor Conferences in May	NASDAQ:TNOX	Tanox (MM)
10/04/2006	14:00	PR Newswire (US)	Tanox to Report First Quarter 2006 Financial Results, Host Conference Call for Investors May 2	NASDAQ:TNOX	Tanox (MM)
28/02/2006	08:30	PR Newswire (US)	Tanox Reports Fourth Quarter and Full Year 2005 Results	NASDAQ:TNOX	Tanox (MM)
09/02/2006	17:00	PR Newswire (US)	New Research Reaffirms Tropism Independence of TNX-355; Data for Tanox's Novel HIV Viral Entry Inhibitor Presented at 2006 CROI	NASDAQ:TNOX	Tanox (MM)
09/02/2006	01:30	PR Newswire (US)	Tanox to Report 2005 Fourth Quarter and Full Year Results Feb. 28	NASDAQ:TNOX	Tanox (MM)
03/02/2006	13:34	PR Newswire (US)	Tanox to Present at Two Investor Conferences in February	NASDAQ:TNOX	Tanox (MM)
23/01/2006	10:00	PR Newswire (US)	Tanox Receives Multimillion Xolair(R) Milestone Payment	NASDAQ:TNOX	Tanox (MM)
04/01/2006	16:29	PR Newswire (US)	Tanox to Present at JP Morgan Healthcare Conference	NASDAQ:TNOX	Tanox (MM)
20/12/2005	17:14	PR Newswire (US)	Tanox Submits Investigational New Drug Application for TNX-650 for Treatment of Hodgkin's Lymphoma	NASDAQ:TNOX	Tanox (MM)
17/12/2005	16:30	PR Newswire (US)	Data Indicates Tanox HIV Drug Candidate Active In Vitro Against CCR5 and CXCR4 Viruses and Synergistic with Entry Inhibitor	NASDAQ:TNOX	Tanox (MM)
17/12/2005	13:30	PR Newswire (US)	Additional Phase 2 Data Supports Further Development of Tanox's Novel HIV Therapy	NASDAQ:TNOX	Tanox (MM)